In Novo Nordisk we strive to make procurement decisions that enhances our goal of having zero environmental impact and ensures ethical and responsible business conduct in our supply chain.

These aspirations are outlined through our two sustainability programs; Responsible Sourcing and Suppliers for Zero which can be further investigated below.

The Novo Nordisk Responsible Sourcing (RS) Program reflects our commitment to work with suppliers who are aligned with our values, and we expect all our suppliers globally to apply these standards within their own organisation and their respective value chains.

Through shared values and a commitment to responsible business conduct, we aim to create a virtuous circle that delivers positive impacts on millions of lives worldwide.

The Responsible Sourcing Standard (RSS) is developed to provide comprehensive guidance of Novo Nordisk minimum requirements for human rights, social, health & safety, and the environment.

To learn more, visit: Responsible Sourcing Standard

The ambition of our environment strategy is bold and simple: to have zero environmental impact.

Since over 95% of our environmental impact lies outside our own operations, we know that real progress depends on what happens in our supply chain. That’s why working together with our suppliers and CMOs is essential.

Our Suppliers for Zero programme outline how we will work together to reach our environmental targets.

To learn more, visit: Suppliers for Zero

As a global company, we work across many diverse cultures where concepts of appropriate business conduct can vary widely. We believe ethical business conduct is about values and integrity as well as compliance and risk mitigation.

Taking a proactive approach in ethical business conduct increases trust in our company and improves relationships with key stakeholders.

We are always ethical in our conduct and never compromise on Business Ethics and we expect the same from our business partners, this is critical to safeguard our license to operate.

Suppliers should always be compliant with local and international anti-corruption laws, principles, standards and codes (including codes developed by patient organisations) and ensure transparency in all interactions. We risk assess our suppliers for business ethics issues and put actions in place to mitigate these as relevant.

To learn more, visit: Business Ethics at Novo Nordisk